Preetam Shah - Net Worth and Insider Trading
Preetam Shah Net Worth
The estimated net worth of Preetam Shah is at least $128,318 dollars as of 2024-10-10. Preetam Shah is the CFO & CBO of Cidara Therapeutics Inc and owns about 11,361 shares of Cidara Therapeutics Inc (CDTX) stock worth over $123,267. Preetam Shah is also the EVP, CFO and Treasurer of Brainstorm Cell Therapeutics Inc and owns about 2,440 shares of Brainstorm Cell Therapeutics Inc (BCLI) stock worth over $5,051. Details can be seen in Preetam Shah's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Preetam Shah has not made any transactions after 2024-03-11 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Preetam Shah
Preetam Shah Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Preetam Shah owns 2 companies in total, including Brainstorm Cell Therapeutics Inc (BCLI) , and Cidara Therapeutics Inc (CDTX) .
Click here to see the complete history of Preetam Shah’s form 4 insider trades.
Insider Ownership Summary of Preetam Shah
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| BCLI | Brainstorm Cell Therapeutics Inc | 2019-12-24 | EVP & CFO and Treasurer |
| CDTX | Cidara Therapeutics Inc | 2024-03-11 | CFO & CBO |
Preetam Shah Latest Holdings Summary
Preetam Shah currently owns a total of 2 stocks. Among these stocks, Preetam Shah owns 11,361 shares of Cidara Therapeutics Inc (CDTX) as of March 11, 2024, with a value of $123,267 and a weighting of 96.06%. Preetam Shah also owns 2,440 shares of Brainstorm Cell Therapeutics Inc (BCLI) as of December 24, 2019, with a value of $5,051 and a weighting of 3.94%.
Latest Holdings of Preetam Shah
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| CDTX | Cidara Therapeutics Inc | 2024-03-11 | 11,361 | 10.85 | 123,267 |
| BCLI | Brainstorm Cell Therapeutics Inc | 2019-12-24 | 2,440 | 2.07 | 5,051 |
Holding Weightings of Preetam Shah
Preetam Shah Form 4 Trading Tracker
According to the SEC Form 4 filings, Preetam Shah has made a total of 4 transactions in Cidara Therapeutics Inc (CDTX) over the past 5 years, including 1 buys and 3 sells. The most-recent trade in Cidara Therapeutics Inc is the sale of 947 shares on March 11, 2024, which brought Preetam Shah around $12,684.
According to the SEC Form 4 filings, Preetam Shah has made a total of 1 transactions in Brainstorm Cell Therapeutics Inc (BCLI) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Brainstorm Cell Therapeutics Inc is the acquisition of 773 shares on December 24, 2019, which cost Preetam Shah around $45,936.
Insider Trading History of Preetam Shah
- 1
Preetam Shah Trading Performance
GuruFocus tracks the stock performance after each of Preetam Shah's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Preetam Shah is -16.27%. GuruFocus also compares Preetam Shah's trading performance to market benchmark return within the same time period. The performance of stocks bought by Preetam Shah within 3 months outperforms 1 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Preetam Shah's insider trading performs compared to the benchmark.
Performance of Preetam Shah
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 4.27 | | | | | |
| Relative Return to S&P 500(%) | 2.84 | | | | | |
Preetam Shah Ownership Network
Preetam Shah Owned Company Details
What does Brainstorm Cell Therapeutics Inc do?
Who are the key executives at Brainstorm Cell Therapeutics Inc?
Preetam Shah is the EVP & CFO and Treasurer of Brainstorm Cell Therapeutics Inc. Other key executives at Brainstorm Cell Therapeutics Inc include Chief Executive Officer Chaim Lebovits , EVP & Head Global Clin Research Stacy Lindborg , and Chief Medical Officer Kirk Taylor .
Brainstorm Cell Therapeutics Inc (BCLI) Insider Trades Summary
Over the past 18 months, Preetam Shah made no insider transaction in Brainstorm Cell Therapeutics Inc (BCLI). Other recent insider transactions involving Brainstorm Cell Therapeutics Inc (BCLI) include a net purchase of 590,208 shares made by Chaim Lebovits , a net sale of 63,000 shares made by , and a net purchase of 11,500 shares made by Stacy Lindborg .
In summary, during the past 3 months, insiders sold 4,200 shares of Brainstorm Cell Therapeutics Inc (BCLI) in total and bought 23,836 shares, with a net purchase of 19,636 shares. During the past 18 months, 4,200 shares of Brainstorm Cell Therapeutics Inc (BCLI) were sold and 62,361 shares were bought by its insiders, resulting in a net purchase of 58,161 shares.
Brainstorm Cell Therapeutics Inc (BCLI)'s detailed insider trading history can be found in Insider Trading Tracker table.
Brainstorm Cell Therapeutics Inc Insider Transactions
Preetam Shah Mailing Address
Above is the net worth, insider trading, and ownership report for Preetam Shah. You might contact Preetam Shah via mailing address: C/o Brainstorm Cell Therapeutics, Inc., 1325 Avenue Of Americas, 28th Flr., New York Ny 10019.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
